Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Aveo Pharmaceuticals Inc (NASDAQ:AVEO)

0.9869
Delayed Data
As of Jul 25
 -0.0331 / -3.25%
Today’s Change
0.82
Today|||52-Week Range
2.59
-21.67%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2015
Quarter 3
2015
Quarter 4
2015
Quarter 1
2016
Revenue and IncomeNet Revenues134.0K15.2M3.6M1.2M
 
 
 
 
 
Depreciation And Amortization--97.0K6.0K5.0K
 
 
 
 
 
Operating ExpensesGross Income----------
General Expenses4.7M6.6M9.7M8.4M
 
 
 
 
 
Research And Development--4.4M3.9M6.0M
 
 
 
 
Total Operating Expenses4.7M6.7M9.7M8.4M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-4.6M8.5M-6.1M-7.2M
 
 
 
 
 
Extraordinary Charge-25.0K----0.00
 
 
Interest Expense On Debt633.0K533.0K425.0K386.0K
 
 
 
 
 
Other Expenses-209.0K-22.0K-44.0K-9.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-5.5M7.9M-6.6M-7.6M
 
 
 
 
 
Income Taxes0.000.000.00-100.0K
 
 
Net Income-5.5M7.9M-6.6M-7.7M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS55.2M56.8M58.1M58.2M
 
 
 
 
 
Shares To Calculate EPS Diluted55.2M57.0M58.1M58.2M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.10$0.14-$0.11-$0.13
 
 
 
 
 
EPS Diluted-$0.10$0.14-$0.11-$0.13